Syrian conjoined twins arrive in Riyadh amid separation surgery hopes

1 / 5
Syrian conjoined twins Ehsan and Bassam arrive at King Khalid International Airport in Riyadh. (Supplied)
2 / 5
Syrian conjoined twins Ehsan and Bassam arrive at King Khalid International Airport in Riyadh. (Supplied)
3 / 5
Syrian conjoined twins Ehsan and Bassam arrive at King Khalid International Airport in Riyadh. (Supplied)
4 / 5
Syrian conjoined twins Ehsan and Bassam arrive at King Khalid International Airport in Riyadh. (Supplied)
5 / 5
Syrian conjoined twins Ehsan and Bassam arrive at King Khalid International Airport in Riyadh. (Supplied)
Short Url
Updated 22 May 2023
Follow

Syrian conjoined twins arrive in Riyadh amid separation surgery hopes

  • Twins transferred to King Abdullah Specialized Children’s Hospital
  • Hopes that a successful separation surgery can be carried out

RIYADH: Syrian conjoined twins Ehsan and Bassam have arrived in Saudi Arabia amid hopes that a successful separation surgery could be carried out.

The Saudi medical evacuation plane carrying the pair, accompanied by their parents, landed at King Khalid International Airport in Riyadh from Ankara, Turkiye, on Monday.

Upon their arrival, the twins were transferred to King Abdullah Specialized Children’s Hospital so doctors could study their condition and consider the possibility of conducting an operation to separate them.

Dr. Abdullah Al-Rabiah, the head of the medical team and general supervisor of the King Salman Humanitarian Aid and Relief Center, extended his gratitude to King Salman and Crown Prince Mohammed bin Salman for supporting the program to separate conjoined twins.

He added that the “noble humanitarian initiative…embodies Saudi Arabia’s superior medical capabilities” and comes in line with the objectives of Saudi Vision 2030 to develop the health sector in the Kingdom.

The parents of the twins expressed their joy and sincere thanks to the king and the crown prince.


Saudi hospital pioneers preventive type 1 diabetes treatment

KFSH&RC has introduced a groundbreaking preventive treatment aimed at slowing the progression of type 1 diabetes. (SPA)
Updated 59 min 11 sec ago
Follow

Saudi hospital pioneers preventive type 1 diabetes treatment

  • The new therapy is designed for adults and children aged eight years and older who are diagnosed at stage two of the disease

RIYADH: King Faisal Specialist Hospital and Research Center introduced a groundbreaking preventive treatment aimed at slowing the progression of type 1 diabetes, the Saudi Press Agency reported on Wednesday.
The new therapy is designed for adults and children aged eight years and older who are diagnosed at stage two of the disease. It marks the first time such a treatment has been implemented in the Kingdom.
The initial application involved two patients who met all the criteria outlined in the approved protocol. The step represents a major advance in early preventive care for one of the most common autoimmune conditions affecting children and adolescents.
Both cases were treated at the hospital’s Department of Pediatrics. For families already managing type 1 diabetes, the innovation brings new hope.
Siblings of affected children often face increased risk due to shared genetic and immune factors. Preventive options like this could significantly lower those risks in the future.
The treatment targets the early, pre-type 1 diabetes stage when insulin-producing pancreatic cells begin to deteriorate. Through early intervention, doctors can slow this damage, delay the onset of symptoms and help extend the time before full disease progression.
Implementing the therapy required careful preparation. The drug was compounded in the hospital pharmacy under a precise protocol, while nursing teams received training on administration, monitoring and managing possible reactions.
Medical staff were also briefed on patient selection and follow-up criteria based on the latest clinical guidelines.
According to the SPA, experts expect the program to inspire national research focused on the early stages of the disease and on developing preventive approaches that enhance quality of life for at-risk groups.
KFSH&RC continues to gain recognition on the global stage. It was ranked first in the Middle East and Africa, and 15th worldwide among the top 250 academic medical centers for 2025.
The hospital was also named the most valuable healthcare brand in Saudi Arabia and the Middle East by Brand Finance 2025.
Additionally, Newsweek included KFSH&RC on its lists of the World’s Best Hospitals (2025), the World’s Smartest Hospitals (2026) and the World’s Best Specialized Hospitals (2026).